Stock 897 WAI YUEN TONG MEDICINE HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Wai Yuen Tong Medicine Holdings Limited

Equities

897

BMG9421Y2332

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:22 2024-04-29 am EDT 		5-day change 1st Jan Change
0.231 HKD +0.43% Intraday chart for Wai Yuen Tong Medicine Holdings Limited -4.94% -42.25%
Apr. 02 Wai Yuen Tong Medicine Holdings Limited commences an Equity Buyback Plan for 117,110,288 shares, representing 10% of its issued share capital, under the authorization approved on August 22, 2023. CI
Mar. 28 Wai Yuen Tong Medicine Holdings Limited Announces Changes of Company Secretary, with Effect from 1 April 2024 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 404.8 307.9 344.9 412.6 357.2 433.7
Enterprise Value (EV) 1 783.4 256.9 1,707 1,529 1,532 1,630
P/E ratio -3.5 x 4.18 x 3.6 x -1.1 x -3.28 x -21.3 x
Yield - - - - - -
Capitalization / Revenue 0.48 x 0.41 x 0.56 x 0.37 x 0.26 x 0.34 x
EV / Revenue 0.93 x 0.34 x 2.75 x 1.38 x 1.1 x 1.27 x
EV / EBITDA -12.1 x -2.68 x -20.9 x 21 x 11.7 x 15.1 x
EV / FCF -3.65 x -14.7 x -3.96 x 4.87 x 68.3 x -70 x
FCF Yield -27.4% -6.81% -25.3% 20.5% 1.46% -1.43%
Price to Book 0.16 x 0.13 x 0.15 x 0.16 x 0.14 x 0.18 x
Nbr of stocks (in thousands) 1,265,143 1,231,643 1,231,643 1,231,643 1,231,643 1,204,643
Reference price 2 0.3200 0.2500 0.2800 0.3350 0.2900 0.3600
Announcement Date 7/26/18 7/30/19 7/22/20 7/26/21 7/22/22 7/27/23
1HKD in Million2HKD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 845.8 751.4 620.7 1,109 1,391 1,286
EBITDA 1 -64.9 -95.81 -81.59 72.83 130.6 108.1
EBIT 1 -111.7 -147.1 -132.4 13.83 69.58 53.44
Operating Margin -13.21% -19.58% -21.32% 1.25% 5% 4.15%
Earnings before Tax (EBT) 1 -114.9 81.69 110.6 -303.1 -47.3 -11.94
Net income 1 -115.6 74.63 95.82 -376 -108.9 -20.52
Net margin -13.67% 9.93% 15.44% -33.92% -7.83% -1.59%
EPS 2 -0.0914 0.0598 0.0778 -0.3053 -0.0884 -0.0169
Free Cash Flow 1 -214.5 -17.48 -430.9 313.8 22.41 -23.28
FCF margin -25.37% -2.33% -69.42% 28.3% 1.61% -1.81%
FCF Conversion (EBITDA) - - - 430.82% 17.16% -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 7/26/18 7/30/19 7/22/20 7/26/21 7/22/22 7/27/23
1HKD in Million2HKD
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 379 - 1,362 1,117 1,174 1,196
Net Cash position 1 - 51.1 - - - -
Leverage (Debt/EBITDA) -5.833 x - -16.69 x 15.33 x 8.994 x 11.07 x
Free Cash Flow 1 -215 -17.5 -431 314 22.4 -23.3
ROE (net income / shareholders' equity) -4.49% 2.97% 3.22% -11.4% -2.22% 0.09%
ROA (Net income/ Total Assets) -1.93% -2.59% -1.48% 0.11% 0.56% 0.46%
Assets 1 5,984 -2,885 -6,478 -341,503 -19,490 -4,487
Book Value Per Share 2 2.020 1.980 1.870 2.080 2.040 1.950
Cash Flow per Share 2 0.3300 0.1400 0.3900 0.4100 0.4100 0.4400
Capex 1 63.6 17 6.81 59.5 26 33.4
Capex / Sales 7.52% 2.26% 1.1% 5.37% 1.87% 2.6%
Announcement Date 7/26/18 7/30/19 7/22/20 7/26/21 7/22/22 7/27/23
1HKD in Million2HKD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Alternative Medicine

1st Jan change Capi.
WAI YUEN TONG MEDICINE HOLDINGS LIMITED Stock Wai Yuen Tong Medicine Holdings Limited
-42.25% 33.06M
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+37.08% 5.92B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-17.43% 4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-9.46% 3.15B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+0.51% 3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-3.53% 2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+41.15% 1.97B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-5.15% 1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
+0.09% 1.65B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-10.38% 1.53B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. 897 Stock
  4. Financials Wai Yuen Tong Medicine Holdings Limited